Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| PROCEPT BioRobotics CorpPRCT · Entity 4831 | EVP, CLO, CORP. SEC. | September 09, 2026 | September 10, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
PROCEPT BioRobotics Corp
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 127,737 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Sale · Disposed 297 · Balance 127,737 F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. |
Filing footnotes · ownership attribution and instrument terms
F1: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026.
Past disclosures · reporting ended (1)
No longer tracked through insider filings. These historical balances do not imply present ownership or a zero position.
ACCURAY INC
Report date July 03, 2018 · Filed July 07, 2018 · Amendment
Section 16 reporting ended · disclosed 2018-07-07. Current position is not established by this disclosure.
Amendment: balances below belong to this corrected disclosure, not necessarily a complete replacement of earlier positions.
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 195,697 |
Reported balance
After 2018-07-03 transaction · row 1
Amendment: may correct only part of an earlier disclosure.
1 source rowRow 1 · 2018-07-03 · Sale · Disposed 8,786 · Balance 195,697 F1: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States. |
Filing footnotes · ownership attribution and instrument terms
F1: Shares were automatically sold in accordance with Accuray policy for all restricted stock unit (RSU) releases in order to cover tax obligations upon RSU release and is consistent with Accuray practices for all RSU releases of employees located in the United States.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:45 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 297 | $20.95 | $6,223.04 |
DisclosureSEC source: 0001599418-26-000002 · wk-form4_1789073123.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 127,737 F1 · kind: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on September 5, 2026. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:36 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 31,773 | $0.00 Strike: $21.95 | $0.00 |
DisclosureSEC source: 0001628280-26-057165 · wk-form4_1786739772.xml · derivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,773 Underlying: Common Stock · 31,773 shares Expires 2036-08-12 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of August 13, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| August 13, 2026 Filed Aug 14, 2026 20:36 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 22,965 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-057165 · wk-form4_1786739772.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 128,034 F1 · shares: 1. These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on August 13, 2027, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. The grant is intended to be 50% of the value of the Reporting Person's expected 2027 grant, and made in lieu of such portion of the expected 2027 grant. Read SEC document |
| June 08, 2026 Filed Jun 10, 2026 20:21 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 285 | $28.48 | $8,116.52 |
DisclosureSEC source: 0001628280-26-042223 · wk-form4_1781122886.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 105,069 F1 · shares: The shares were sold by the reporting person pursuant to the Issuer's sell-to-cover process for tax withholding obligations in connection with the vesting of the Restricted Stock Units on June 5, 2026. Read SEC document |
| March 19, 2026 Filed Mar 19, 2026 21:47 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 2,332 | $26.15 | $60,972.47 |
DisclosureSEC source: 0001628280-26-019900 · wk-form4_1773956826.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 105,354 F1 · kind: The stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.025 to $26.450, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 19, 2026 Filed Mar 19, 2026 21:47 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,031 | $25.82 | $78,258.30 |
DisclosureSEC source: 0001628280-26-019900 · wk-form4_1773956826.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 107,686 F1 · kind: The stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.025 to $26.020, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 17, 2026 Filed Mar 19, 2026 20:25 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 304 | $28.15 | $8,558.57 |
DisclosureSEC source: 0001628280-26-019833 · wk-form4_1773951955.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 110,717 F1 · shares: The shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 145 | $26.74 | $3,877.00 |
DisclosureSEC source: 0001628280-26-017218 · wk-form4_1773345751.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,021 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.365 to $26.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 10, 2026 Filed Mar 12, 2026 20:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,098 | $25.60 | $79,320.26 |
DisclosureSEC source: 0001628280-26-017218 · wk-form4_1773345751.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 111,166 F1 · kind: The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 4, 2025. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25.11 to $25.96 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote. Read SEC document |
| March 06, 2026 Filed Mar 9, 2026 21:43 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 6,892 | $23.70 | $163,353.49 |
DisclosureSEC source: 0001628280-26-016153 · wk-form4_1773092610.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 114,264 F2 · shares: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units and Performance Stock Units. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:43 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 29,615 | $0.00 Strike: $25.35 | $0.00 |
DisclosureSEC source: 0001628280-26-016153 · wk-form4_1773092610.xml · derivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,615 Underlying: Common Stock · 29,615 shares Expires 2036-03-04 F3 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2026, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 05, 2026 Filed Mar 9, 2026 21:43 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 43,811 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-016153 · wk-form4_1773092610.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 121,156 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2027, with onesixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| February 19, 2026 Filed Feb 25, 2026 21:47 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 4,872 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-26-011747 · wk-form4_1772056048.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,345 F1 · shares: Represents shares of common stock underlying a portion of an award of performance stock units ("PSUs") previously granted by the Issuer, the vesting of which was subject to the Issuer's achievement of certain pre-determined performance criteria. Upon certification by the Issuer's Compensation Committee on February 19, 2026, of the achievement of such performance criteria, the number of PSUs reported herein was deemed earned, which will vest on March 5, 2026. Each PSU represents a contingent right to receive one share of the Issuer's common stock. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 20:15 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,000 | $0.00 Strike: $4.52 | $0.00 |
DisclosureSEC source: 0001628280-25-040389 · wk-form4_1755202552.xml · derivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 54,452 Underlying: Common Stock · 11,000 shares Expires 2028-09-27 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: Transaction is a cash exercise by the reporting person. F2 · derivative.exercise_date: The option is fully vested and exercisable. Read SEC document |
| August 14, 2025 Filed Aug 14, 2025 20:15 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 11,000 | $4.52 | $49,720.00 |
DisclosureSEC source: 0001628280-25-040389 · wk-form4_1755202552.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 72,473 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2025 Filed Mar 19, 2025 20:04 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 316 | $57.06 | $18,030.96 |
DisclosureSEC source: 0001628280-25-013813 · wk-form4_1742414660.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,473 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2025 Filed Mar 10, 2025 20:31 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,641 | $61.31 | $223,229.71 |
DisclosureSEC source: 0001628280-25-011710 · wk-form4_1741638660.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,789 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:36 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 11,445 | $0.00 Strike: $60.60 | $0.00 |
DisclosureSEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · derivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,445 Underlying: Common Stock · 11,445 shares Expires 2035-03-02 F2 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2025, over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 03, 2025 Filed Mar 5, 2025 22:36 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 12,958 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-25-010628 · wk-form4_1741214157.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,430 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. One-quarter of the RSUs shall vest on March 5, 2026, with one-sixteenth of the remaining RSUs vesting quarterly over 36 months, subject to the Reporting Person continuing as a service provider through such date. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 12,092 | $0.00 Strike: $37.02 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 9 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,094 Underlying: Common Stock · 12,092 shares Expires 2033-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The Stock option was granted on March 5, 2023 and vests 1/48th of the shares monthly from the vesting commencement date of March 5, 2023 over a four year period thereafter, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 4,162 | $0.00 Strike: $34.99 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 8 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 2,728 Underlying: Common Stock · 4,162 shares Expires 2032-03-30 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Stock option was granted on March 31, 2022 and vested 1/48th on the anniversary of the vesting commencement date of March 15, 2022, and vesting monthly over a four year period thereafter, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 11,838 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · derivative · entry 7 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 21,056 Underlying: Common Stock · 11,838 shares Expires 2031-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F5 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vested over a four year period. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 8,118 | $97.90 | $794,752.20 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 6 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,472 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $97.58 to $98.24, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 16,187 | $96.98 | $1,569,815.26 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 5 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 60,590 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $96.56 to $97.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 3,787 | $96.12 | $364,006.44 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 4 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 76,777 F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the reporting person on September 3, 2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $95.55 to $96.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 12,092 | $37.02 | $447,645.84 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 80,564 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 4,162 | $34.99 | $145,628.38 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 68,472 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| December 04, 2024 Filed Dec 6, 2024 21:17 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 11,838 | $7.27 | $86,062.26 |
DisclosureSEC source: 0001628280-24-050221 · wk-form4_1733519866.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 64,310 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 21:32 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 1,048 | $63.30 | $66,337.98 |
DisclosureSEC source: 0001628280-24-028866 · wk-form4_1718746356.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 52,472 F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/13/2024. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.66 to $63.44, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| June 17, 2024 Filed Jun 18, 2024 21:32 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 8,952 | $62.04 | $555,425.94 |
DisclosureSEC source: 0001628280-24-028866 · wk-form4_1718746356.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 53,520 F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/13/2024. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.64 to $62.62, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 25,000 | $0.00 Strike: $7.27 | $0.00 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · derivative · entry 11 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 32,894 Underlying: Common Stock · 25,000 shares Expires 2031-06-21 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F8 · derivative.exercise_date: The Stock option was granted on June 22, 2021 and vests 25% on the six month anniversary of June 22, 2021 and the remainder vests on each monthly anniversary over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 3,965 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · derivative · entry 10 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,160 Underlying: Common Stock · 3,965 shares Expires 2030-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F7 · derivative.exercise_date: The Stock option was granted on August 10, 2020 and vests 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 1,467 | $0.00 Strike: $4.56 | $0.00 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · derivative · entry 9 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,230 Underlying: Common Stock · 1,467 shares Expires 2029-12-11 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F6 · derivative.exercise_date: The Stock option was granted on December 12, 2019 and vests on each monthly anniversary of the grant date over a four year period, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 133 | $64.04 | $8,517.32 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 8 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,472 F5 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $64.02 to $64.11, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 14,437 | $63.38 | $915,017.06 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 7 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,605 F4 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.00 to $63.94, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 13,935 | $62.79 | $874,978.65 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 6 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 77,042 F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $62.00 to $62.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 1,536 | $61.28 | $94,126.08 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 5 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 90,977 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $61.00 to $61.81, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 391 | $60.84 | $23,788.44 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 4 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,513 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $60.67 to $60.95, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 25,000 | $7.27 | $181,750.00 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 92,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 3,965 | $5.18 | $20,538.70 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,904 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| May 03, 2024 Filed May 4, 2024 01:40 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 1,467 | $4.56 | $6,689.52 |
DisclosureSEC source: 0001628280-24-020433 · wk-form4_1714786824.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 63,939 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| March 18, 2024 Filed Mar 20, 2024 20:52 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 441 | $48.83 | $21,534.03 |
DisclosureSEC source: 0001628280-24-012241 · wk-form4_1710967941.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,472 F1 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on March 31, 2022. F2 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:53 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantStock Option (Right to Buy) · Derivative | 15,949 | $0.00 Strike: $47.17 | $0.00 |
DisclosureSEC source: 0001628280-24-009766 · wk-form4_1709859192.xml · derivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,949 Underlying: Common Stock · 15,949 shares Expires 2034-03-05 F4 · derivative.exercise_date: 1/48th of the shares subject to the Stock Option shall vest monthly from the vesting commencement date of March 5, 2024 over a four year period, subject continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:53 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 2,749 | $46.67 | $128,295.83 |
DisclosureSEC source: 0001628280-24-009766 · wk-form4_1709859192.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,913 F2 · kind: These shares were sold by the reporting person to cover tax withholding obligations in connection with the vesting of the Restricted Stock Units granted on February 16, 2023. F3 · price: The price reported in Column 4 is a weighted average price. Read SEC document |
| March 06, 2024 Filed Mar 8, 2024 00:53 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | GrantCommon Stock | 18,311 | $0.00 | $0.00 |
DisclosureSEC source: 0001628280-24-009766 · wk-form4_1709859192.xml · nonDerivative · entry 1 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 65,662 F1 · shares: These securities are restricted stock units (RSUs). Each RSU represents a contingent right to receive one share of Common Stock. 1/4th of the RSUs shall vest on the anniversary of the vesting commencement date of March 5, 2024, and annually over a three year period thereafter, subject to continued employment or service by the Reporting Person to the Issuer through the applicable vesting date. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 14,694 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · derivative · entry 6 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 20,125 Underlying: Common Stock · 14,694 shares Expires 2030-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. F4 · derivative.exercise_date: The Stock option was granted on August 10, 2020 and vested 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 14,694 | $49.97 | $734,313.55 |
DisclosureSEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · nonDerivative · entry 4 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,351 F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. F3 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.02, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
| February 09, 2024 Filed Feb 9, 2024 22:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionCommon Stock | 14,694 | $5.18 | $76,114.92 |
DisclosureSEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · nonDerivative · entry 3 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 62,045 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | Exercise / conversionStock Option (Right to Buy) · Derivative | 5,306 | $0.00 Strike: $5.18 | $0.00 |
DisclosureSEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · derivative · entry 5 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 34,819 Underlying: Common Stock · 5,306 shares Expires 2030-08-08 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. F4 · derivative.exercise_date: The Stock option was granted on August 10, 2020 and vested 12.5% on the six month anniversary of August 1, 2020 and the remainder on each monthly anniversary over a three and a half year period, subject continued employment or service to the Issuer through the applicable vesting date. Read SEC document |
| February 07, 2024 Filed Feb 9, 2024 22:02 UTC | PROCEPT BioRobotics Corp PRCT · Entity 4831 | SaleCommon Stock | 5,306 | $49.95 | $265,053.27 |
DisclosureSEC source: 0001628280-24-004111 · wk-form4_1707516153.xml · nonDerivative · entry 2 Nouri Alaleh · CIK 0001599418 · EVP, CLO, CORP. SEC. 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 47,351 F1 · kind: All transactions reported here were affected pursuant to Rule 10b5-1 Plan adopted by the reporting person on 3/7/2023. F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $49.95 to $50.00, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.